06 | Nirsevimab as a key strategy to prevent respiratory syncytial virus among newborns and children: real-world evidence from Italy and Sicily. (2026). EuroMediterranean Biomedical Journal, 21(s1). https://doi.org/10.3269/q1nt4g06